Clinical Trials Logo

Sleep Apnea, Obstructive clinical trials

View clinical trials related to Sleep Apnea, Obstructive.

Filter by:

NCT ID: NCT04142905 Active, not recruiting - Asthma Clinical Trials

Is Asthma in Subjects With Obstructive Sleep Apnoea (OSA) Due to Dysanapsis

Start date: February 10, 2021
Phase:
Study type: Observational

Intention to review patient letters from sleep clinic to see if their lung function fit in with Dysynapsis in wheezing patients or if it is true asthma

NCT ID: NCT03932383 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea

3D Printer Modified CPAP Mask for Obstructive Sleep Apnea

3DCPAP
Start date: April 4, 2018
Phase: N/A
Study type: Interventional

This is a prospective pilot to investigate the effect of 3D printer customized CPAP masks on the comfort of patients with obstructive sleep apnea.

NCT ID: NCT03928665 Active, not recruiting - Glaucoma Clinical Trials

Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea

Start date: October 1, 2012
Phase:
Study type: Observational [Patient Registry]

The ophthalmic changes during long-lasting sleep apnea are lacking in description and assessment. The investigators intend to observe patients for a long time and observe if the changes in eye tissues are progressing over the years in easily recognizable patterns.

NCT ID: NCT03868618 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea

Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM)

DREAM
Start date: October 14, 2020
Phase: N/A
Study type: Interventional

A multicenter study to assess the safety and effectiveness of the Genio dual-sided hypoglossal nerve stimulation system for the treatment of obstructive sleep apnea in adults subjects.

NCT ID: NCT03866148 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Obstructive Sleep Apnoea and Cardiac Arrhythmias

OSCA
Start date: October 3, 2019
Phase: N/A
Study type: Interventional

This study is a prevelance trial looking at how sleep apnoea affects the heart especially heart rhythms. Previous research shows that patients suffering from sleep apnoea are much more likely to get heart disease and abnormal heart rhythms (arrhythmias). These defects are sometimes missed by the traditional methods of monitoring i.e. 24-hour Holter monitor and ECGs. This means potentially dangerous arrhythmias may not be detected. Additionally, standard therapy for sleep apnoea does not significantly reduce the risk of heart disease. This study will recruit 200 participants over a period of 18 months. The research team will observe the heart rhythms of sleep apnoea patients by inserting an implantable loop recorder (ILR) in up to 100 participants. The other 100 patients will simply have standard care. This device will monitor the heart continuously for 3 years allowing us to detect abnormal heart rhythms and treat as necessary. Demonstrating the incidence of arrhythmia can lead onto a larger study which may change future sleep apnoea management improving their cardiovascular outcomes. Other markers of heart disease such as; blood tests, Magnetocardiography and Echocardiography will be performed on participants to shed more light on the mechanisms which link sleep apnoea and heart disease/arrhythmia.

NCT ID: NCT03858244 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea

Idiopathic Scoliosis Progression and Sleep-disordered Breathing in Children

Start date: February 18, 2019
Phase:
Study type: Observational

This study aimed to investigate the prevalence and clinical significance of sleep-disordered breathing (SDB) in children with mild-moderate idiopathic scoliosis (IS).

NCT ID: NCT03819361 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea

Effect of Longitudinal Sleep Monitoring on Diagnosis and Treatment Decision in Patients With Suspected Obstructive Sleep Apnea

ELSA
Start date: February 1, 2019
Phase:
Study type: Observational

Obstructive sleep apnea (OSA) is a highly prevalent sleep-disordered breathing disease, caused by recurrent episodes of partial or complete collapse of the upper airway during sleep, resulting in intermittent hypoxia, fragmented sleep, fluctuations in blood pressure, and increased sympathetic nervous system activity. A single-night sleep study (i.e. respiratory polygraphy or polysomnography) is currently considered to be the gold standard for diagnosing OSA. However, recent studies suggest a significant intra-individual night-to-night variability of respiratory events, leading to the hypothesis that one single-night study might not reflect an accurate picture of the disease. Part A: Patients with suspected obstructive sleep apnea, referred to our clinic, undergo the regular diagnostic procedure recommended by the current guidelines. In addition to the in-hospital single-night sleep study, these patients will perform 14 nights of pulse-oximetry at home. By computing and analysing sensitivity and specificity of every additional night, the investigator will answer the questions how many nights of sleep monitoring by home oximetry are necessary to diagnose OSA reliably, and how longitudinal sleep monitoring could reduce the number of false-negative and false- positive results compared to the in-hospital single-night study. Part B: Based on the patients' data of part A, the investigator will develop a questionnaire and present anonymized cases to experts in the field of sleep medicine. Thereby, the investigator will evaluate if the additional information of repeated nocturnal pulse-oximetries changes the experts' decision making regarding diagnosis and treatment of OSA. In a second step, the investigator will perform a classical Delphi study with a panel of experts in sleep medicine to establish consensus on repeated sleep studies and how they should be used for diagnosis and treatment in patients with suspected OSA.

NCT ID: NCT03771469 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea

Validation of Sleep Questionnaires in the Down Syndrome Population

Start date: June 25, 2018
Phase: N/A
Study type: Interventional

This will be a prospective validation study of a sample of consecutive pediatric Down syndrome patients who are seen through the weekly Down syndrome clinic at OHSU/Doernbecher's. Questionnaires will be administered to approximately 5 new patients per month. Since this population has a higher prevalence of OSA than the general pediatric population, and OSA is a potentially modifiable determinant of quality of life, validated instruments are critical in assessing disease burden and response to treatment.

NCT ID: NCT03763682 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea

BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea With and Without Complete Concentric Collapse

BETTER SLEEP
Start date: January 10, 2019
Phase: N/A
Study type: Interventional

The objective of this study is to explore the safety and performance of the Genioâ„¢ system in adult obstructive sleep apnoea (OSA) patients with and without complete concentric collapse of the soft palate over a period of 4.5 months of treatment (i.e. 6 months post-surgery) measured by the AHI, at rest to determine if there is a difference in performance between the two populations.

NCT ID: NCT03753633 Active, not recruiting - Clinical trials for Sleep Apnea, Obstructive

Efficiency of Speech Therapy in Resistant Hypertensive Patients With Mild Obstructive Sleep Apnea Syndrome

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze the effect of speech therapy on quality of life, sleep quality, daytime sleepiness level and apnea-hypopnea index in patients with hypertensive patients with mild obstructive apnea syndrome.